Consolidated Balance Sheets - USD ($)		Dec. 31, 2024	Dec. 31, 2023
Current Assets
Cash		$ 526	$ 50,433
Other current assets		7,894	38,818
Notes receivable – current portion		371,170
Total Current Assets		379,590	89,251
Non-current assets
Plant and equipment		4,858	7,027
Security deposit			5,000
Equity method investment		1	703,938
Total Non-Current Assets		4,859	715,965
Total Assets		384,449	805,216
Current Liabilities
Accounts payable		2,986,039	2,023,375
Federal relief loans – current portion		8,869	9,369
Notes payable, net of unamortized discount of $89,062 and $0, respectively		1,669,873	1,062,007
Convertible debt, net of unamortized discount of $80,971 and $687,503, respectively		5,016,205	3,704,280
Derivative liability		1,138,204	1,434,196
Total Current Liabilities		10,819,190	8,233,227
Non-Current Liabilities
Federal relief loans		150,000	150,000
Total Non-Current Liabilities		150,000	150,000
Total Liabilities		10,969,190	8,383,227
Stockholders’ Equity (Deficit)
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of December 31, 2024 and December 31, 2023.
Common stock, $0.0001 par value; 750,000,000 shares authorized. 19,081,446 and 13,819,889 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively.*	[1]	1,908	1,382
Additional paid-in-capital	[1]	52,202,117	50,656,225
Accumulated deficit		(62,788,766)	(58,235,618)
Total Stockholders’ Equity (deficit)		(10,584,741)	(7,578,011)
Total Liabilities and Stockholders’ Equity (Deficit)		$ 384,449	$ 805,216

[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.